Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
- PMID: 36156921
- PMCID: PMC9476853
- DOI: 10.3748/wjg.v28.i33.4861
Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
Abstract
Background: The Rome IV criteria eliminated abdominal discomfort for irritable bowel syndrome (IBS), which was previously included in Rome III. There are questions as to whether IBS patients with abdominal discomfort (seen in Rome III but not Rome IV) are different from those with abdominal pain (Rome IV).
Aim: To compare bowel symptoms and psychosocial features in IBS patients diagnosed with Rome III criteria with abdominal discomfort, abdominal pain, and pain & discomfort.
Methods: We studied IBS patients meeting Rome III criteria. We administered the IBS symptom questionnaire, psychological status, and IBS quality of life. Patients were classified according to the predominant abdominal symptom associated with defecation into an only pain group, only discomfort group, and pain & discomfort group. We compared bowel symptoms, extraintestinal symptoms, IBS quality of life, psychological status and healthcare-seeking behaviors, and efficacy among the three groups. Finally, we tested risk factors for symptom reporting in IBS patients.
Results: Of the 367 Rome III IBS patients enrolled, 33.8% (124 cases) failed to meet Rome IV criteria for an IBS diagnosis. There were no meaningful differences between the pain group (n = 233) and the discomfort group (n = 83) for the following: (1) Frequency of defecatory abdominal pain or discomfort; (2) Bowel habits; (3) Coexisting extragastrointestinal pain; (4) Comorbid anxiety and depression; and (5) IBS quality of life scores except more patients in the discomfort group reported mild symptom than the pain group (22.9% vs 9.0%). There is a significant tendency for patients to report their defecatory and non-defecatory abdominal symptom as pain alone, or discomfort alone, or pain & discomfort (all P < 0.001).
Conclusion: IBS patients with abdominal discomfort have similar bowel symptoms and psychosocial features to those with abdominal pain. IBS symptoms manifesting abdominal pain or discomfort may primarily be due to different sensation and reporting experience.
Keywords: Abdominal discomfort; Abdominal pain; Diagnosis; Irritable bowel syndrome; Psychosocial distress; Quality of life.
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: There are no conflicts of interest to report.
Figures



Similar articles
-
Gender differences in gastrointestinal, biopsychosocial and healthcare-seeking behaviors in Chinese patients with irritable bowel syndrome predominant with diarrhea.BMC Gastroenterol. 2024 Mar 13;24(1):102. doi: 10.1186/s12876-024-03153-7. BMC Gastroenterol. 2024. PMID: 38481138 Free PMC article.
-
Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.Neurogastroenterol Motil. 2018 Feb;30(2). doi: 10.1111/nmo.13189. Epub 2017 Aug 14. Neurogastroenterol Motil. 2018. PMID: 28804974 Clinical Trial.
-
How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.Am J Gastroenterol. 2018 Jul;113(7):1017-1025. doi: 10.1038/s41395-018-0074-z. Epub 2018 Jun 8. Am J Gastroenterol. 2018. PMID: 29880963
-
Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria.Clin Nutr. 2023 May;42(5):800-809. doi: 10.1016/j.clnu.2023.03.019. Epub 2023 Mar 31. Clin Nutr. 2023. PMID: 37031468
-
Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol. 2020 Oct;5(10):908-917. doi: 10.1016/S2468-1253(20)30217-X. Epub 2020 Jul 20. Lancet Gastroenterol Hepatol. 2020. PMID: 32702295
Cited by
-
Real-world safety of linaclotide in Chinese patients with irritable bowel syndrome with constipation: a multicenter, single-arm, prospective observational study.Therap Adv Gastroenterol. 2025 Feb 5;18:17562848251314819. doi: 10.1177/17562848251314819. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 39917729 Free PMC article.
-
Cognition of abdominal pain and abdominal discomfort in Chinese patients with irritable bowel syndrome with diarrhea.Biopsychosoc Med. 2023 Sep 8;17(1):31. doi: 10.1186/s13030-023-00286-1. Biopsychosoc Med. 2023. PMID: 37684670 Free PMC article.
-
Gender differences in gastrointestinal, biopsychosocial and healthcare-seeking behaviors in Chinese patients with irritable bowel syndrome predominant with diarrhea.BMC Gastroenterol. 2024 Mar 13;24(1):102. doi: 10.1186/s12876-024-03153-7. BMC Gastroenterol. 2024. PMID: 38481138 Free PMC article.
-
Epidemiology of Disorders of the Gut-Brain Interaction: An Appraisal of the Rome IV Criteria and Beyond.Gut Liver. 2024 Jul 15;18(4):578-592. doi: 10.5009/gnl230396. Epub 2024 Apr 29. Gut Liver. 2024. PMID: 38680110 Free PMC article. Review.
-
Psychological factors may affect the quality of life in irritable bowel syndrome patients more than the gut itself? A multicenter cross-sectional study.JGH Open. 2024 Mar 26;8(3):e13045. doi: 10.1002/jgh3.13045. eCollection 2024 Mar. JGH Open. 2024. PMID: 38544955 Free PMC article.
References
-
- Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, Whitehead WE, Dumitrascu DL, Fang X, Fukudo S, Kellow J, Okeke E, Quigley EMM, Schmulson M, Whorwell P, Archampong T, Adibi P, Andresen V, Benninga MA, Bonaz B, Bor S, Fernandez LB, Choi SC, Corazziari ES, Francisconi C, Hani A, Lazebnik L, Lee YY, Mulak A, Rahman MM, Santos J, Setshedi M, Syam AF, Vanner S, Wong RK, Lopez-Colombo A, Costa V, Dickman R, Kanazawa M, Keshteli AH, Khatun R, Maleki I, Poitras P, Pratap N, Stefanyuk O, Thomson S, Zeevenhooven J, Palsson OS. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021;160:99–114.e3. - PubMed
-
- Drossman DA, Corazziari E, Delvaux M. Rome III-functional gastrointestinal disorders. 3th ed. BW & A Books, inc: Durham, 2006.
-
- Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel Disorders. Gastroenterology. 2016 - PubMed
-
- Fang X, Francisconi CF, Fukudo S, Gerson MJ, Kang JY, Schmulson W MJ, Sperber AD. Multicultural Aspects in Functional Gastrointestinal Disorders (FGIDs) Gastroenterology. 2016 - PubMed
-
- Spiegel BM, Bolus R, Agarwal N, Sayuk G, Harris LA, Lucak S, Esrailian E, Chey WD, Lembo A, Karsan H, Tillisch K, Talley J, Chang L. Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials. Aliment Pharmacol Ther. 2010;32:1275–1291. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources